The price of GRAL is predicted to go up 4.14%, based on the high correlation periods with CAPL. The similarity of these two price pattern on the periods is 96.25%.
GRAL
CAPL
Up: 4.14%Similarity: 96.25%
GRAL Revenue Forecast
GRAL EPS Forecast
GRAL FAQs
What is GRAL revenue forecast for next quarter?
The market consensus for GRAL's revenue in the upcoming quarter is projected to be approximately $35.8M USD.
Morgan Stanley initiated coverage of Grail with an Equal Weight rating and $16 price target. The company's Galleri multi-cancer early detection screening test has the potential to address a significant unmet need, the analyst tells investors in a research note. The firm says that while Grail's cash preservation efforts are encouraging, with Medicare reimbursement, the key catalyst to unlocking share value, essentially a 2027 dynamic, the stock's near-term risk/reward is balanced.